Nulife Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 25-12-2024
- Paid Up Capital ₹ 7.50 M
as on 25-12-2024
- Company Age 49 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.03 Cr
as on 25-12-2024
- Revenue 13.45%
(FY 2022)
- Profit 219.00%
(FY 2022)
- Ebitda 3.63%
(FY 2022)
- Net Worth 10.72%
(FY 2022)
- Total Assets -6.07%
(FY 2022)
About Nulife Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹1.03 Cr.
Anuradha Trivedi and Umesh Trivedi serve as directors at the Company.
- CIN/LLPIN
U99999MH1975PTC018356
- Company No.
018356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 1975
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nulife Pharmaceuticals Private Limited offer?
Nulife Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Plastic Containers & Bottles, Pharmaceutical Containers.
Who are the key members and board of directors at Nulife Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Trivedi  | Managing Director | 30-Jun-1984 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuradha Trivedi | Director | 01-Apr-2010 | Current |
Financial Performance of Nulife Pharmaceuticals.
Nulife Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.45% increase. The company also saw a substantial improvement in profitability, with a 219% increase in profit. The company's net worth Soared by an impressive increase of 10.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nulife Pharmaceuticals?
Unlock access to Nulife Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 14 May 2007 | ₹1.00 M | Open |
Bank Of India Creation Date: 14 May 2007 | ₹7.30 M | Open |
Bank Of Indai Creation Date: 23 Mar 1991 | ₹1.84 M | Open |
How Many Employees Work at Nulife Pharmaceuticals?
Unlock and access historical data on people associated with Nulife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nulife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nulife Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
